Showing results (31-40 of 69) with videos related to
Sort By:
Pageof 7
International Journal of Urology : Official Journal of the Japanese Urological Association|January 7, 2026
Risk Assessment of Cytomegalovirus Reactivation After Kidney Transplantation Under a Universal Preemptive Strategy in the Era of Intravenous Immunoglobulin-Based Desensitization TherapyYu Kijima, Toshihito Hirai, Shuhei Nozaki, et al.Clinical and Experimental Nephrology|May 13, 2026
Efficacy and safety of reduced-dose valganciclovir prophylaxis for cytomegalovirus infection after pediatric kidney transplantationRyo Nakatani, Yoko Shirai, Taro Ando, et al.Clinical and Experimental Nephrology|April 14, 2024
Renal outcome of living kidney donors aged more than 70 yearsRikako Oki, Kohei Unagami, Taro Banno, et al.Scandinavian Journal of Immunology|March 5, 2024
Comparison of BNT162b2 and mRNA1273 vaccines in solid organ transplant recipients: Post-Hoc analysis of a Japanese national prospective studyMikiko Yoshikawa, Yoichiro Natori, Rikako Oki, et al.Transplantation Proceedings|February 13, 2022
Safe Renal Transplantation to the Extraperitoneal Cavity in Children Weighing Less Than 15 kgKeisuke Hata, Hideki Ishida, Kiyonobu Ishizuka, et al.In Vivo (Athens, Greece)|April 27, 2023
Long-time Survival of a Renal Transplant Recipient With Metastatic Mucinous Tubular and Spindle Cell Carcinoma: A Case ReportYuki Kobari, Kazuhiko Yoshida, Ryo Minoda, et al.IJU Case Reports|March 5, 2024
En bloc kidney transplantation from pediatric donors to teenage recipients: Two case reportsTakafumi Yagisawa, Taichi Kanzawa, Toshihito Hirai, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|February 19, 2024
Higher Donor Age and Severe Microvascular Inflammation Are Risk Factors for Chronic Rejection After Treatment of Active Antibody-Mediated RejectionTaro Banno, Toshihito Hirai, Rikako Oki, et al.Nephrology (Carlton, Vic.)|July 4, 2018
A case of recurrent proliferative glomerulonephritis with monoclonal IgG deposits or de novo C3 glomerulonephritis after kidney transplantationTomomi Tamura, Kohei Unagami, Masayoshi Okumi, et al.Clinical and Experimental Nephrology|April 13, 2024
Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 studyHideki Ishida, Norihiko Goto, Ryoichi Imamura, et al.Pageof 7